Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Navicam for Detection of Barrett's Esophagus

NCT: NCT06748911 · RECRUITING

NCT IDNCT06748911
StatusRECRUITING
Start Date2025-02-20
Completion2026-06-30

Brief Summary

Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus

Frequently Asked Questions

What is Navicam for Detection of Barrett's Esophagus?

Navicam for Detection of Barrett's Esophagus is a clinical trial registered under NCT06748911. Current status: RECRUITING.

What is the status of NCT06748911?

The current status of NCT06748911 (Navicam for Detection of Barrett's Esophagus) is: RECRUITING.

When did Navicam for Detection of Barrett's Esophagus start?

Navicam for Detection of Barrett's Esophagus started on 2025-02-20.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑